Which anesthetic keeps blood pressure steadier in brain surgery?

NCT ID NCT06091904

Recruiting now Knowledge-focused Sponsor: Seoul National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests two anesthetic drugs, sufentanil and remifentanil, in 92 people having brain bypass surgery. The goal is to see which drug better prevents dangerously low blood pressure during the operation. Researchers will also monitor heart rate and the need for additional blood pressure support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sufentanil and remifentanil (anesthetic drugs)
What this could lead to: If it works, this could point toward a better anesthetic choice to keep blood pressure stable during brain bypass surgery.
What could go wrong: This is a small, early-stage trial (92 people) comparing two drugs already in use, so it won't lead to a new treatment. It only tests which drug works better for this specific surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRAOPERATIVE HYPOTENSION

Contacts and locations

Locations

Seoul National University Bundang Hospital
RECRUITING

Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.